Nuno Prego Ramos

[Canal Q @CanalQ]

Hoje, viver para sempre é a questão. Uma conversa imperdível com Nuno Prego Ramos, fundador e CEO da Valvian, uma empresa que aposta em terapias para a longevidade. Às 23h10, Bitalk, no Q. @bitalk_podcast

[ChampalimaudF @ChampalimaudF]

💡A primeira sessão pública do #InnovationSpeakerSeries com o convidado Nuno Prego Ramos é já no dia 29 de maio - Participem!
🎙️Nuno Prego Ramos, Co-Fundador e CEO da CellmAbs
📅15h
📍Seminar Room, @ChampalimaudF
🎟️Evento gratuito, RSVP: https://t.co/wppGMwI4jM

[P-BIO - Associação Portuguesa de Bioindústria @pbio_pt]

Nuno Prego Ramos, ex-CEO da CellmAbs, revelou na semana passada a sua nova empresa biotecnológica, Valvian, que irá dedicar-se ao desenvolvimento de terapias para ocancro e doenças relacionadas com a idade, utilizando inteligência artificial. Mais: https://t.co/z1z8j84AWZ #PBIO

[TEK Notícias @TeKNoticias_]

A #valvian quer criar centro de excelência em Portugal e de referência na Europa para a área de #biotecnologia.

Leia mais 👇

https://t.co/2eKBFfE08l

[Hugo Séneca @SenecaHugo]

Nuno Prego Ramos quer levar a Valvian para a linha da frente da longevidade, mas não gosta do termo elixir da juventude. Para ouvir no Futuro do Futuro
https://t.co/JasKA086eT
#valvian #célulassenescentes #longevidade #saúde #biotecnologia #envelhecimento #terapia

[Nuno Prego Ramos @NunoPregoRamos]

@elonmusk @DogeDillionaire Older, for sure. Old? Maybe not @elonmusk. But let’s put a pin on the aging topic for now. Will talk soon! ;)

[Nuno Prego Ramos @NunoPregoRamos]

@beatrizramosss_ If @VancityReynolds is going, it's still on for me!

[Nuno Prego Ramos @NunoPregoRamos]

@theryanking True @theryanking! Companies are only great if leaders think wildly different…sometimes it might seem crazy but that’s because great leaders are foreseeing what others are not able to 😉

[Nuno Prego Ramos @NunoPregoRamos]

@JohnCendpts they might have been warned that the Portuguese are already on the way! Not the Armada, of course, the “Discovery” fleet😉

[John D Carroll @JohnCendpts]

And just when you least expect it, the Spanish Armada shows up.

[Chamath Palihapitiya @chamath]

Presidents’ Day pod!!

[F-star, an invoX Company @Fstar_Inc]

At the virtual H.C. Wainwright BioConnect Conference, @EliotForster spoke w/ Patrick Trucchio about our tetravalent #bispecific platform, pipeline and 4 programs in clinical development. Listen to their conversation here: https://t.co/1Hw8HRHx5T
#immunooncology #cancer #biotech

[RApport @rapport_bio]

Biotech board members and management teams want to know how companies can benefit from what RA Capital and others call a “Series I” IPO process (also known as a data-driven or logic-based IPO). @PeterKolchinsky & Tess Cameron answer common questions.

https://t.co/o8f6wigHdd

[Peter Kolchinsky @PeterKolchinsky]

We talked to biotech execs & created Q&A for all executives planning for an IPO. Supplements the modest slide deck that goes through the rationale & process step by step. ——-Practical considerations for conducting a Series I IPO — ⁦@rapport_bio⁩ https://t.co/YPrISdlpTS

[F-star, an invoX Company @Fstar_Inc]

If you're at #SITC21 visit Poster #573 on Preclinical Data Demonstrating Potential for FS120, our First-in-Class OX40/CD137 Tetravalent Dual T Cell Agonist in Combination with Anti-PD-1.
https://t.co/LjVUjcP115

[F-star, an invoX Company @Fstar_Inc]

Big day at F-star! We announced a license agreement with Janssen Biotech, Inc. to research, develop and commercialize up to 5 novel #bispecific antibodies directed to Janssen therapeutic targets using our proprietary Fcab and mAb platforms.

[Peter Kolchinsky @PeterKolchinsky]

For executives who would like their IPO myth-free with a side of logic, we threw together a “few” slides. If this were taught in b-school, might be called “practical finance game theory”, but I hope you just think “common sense”. https://t.co/oTXNhyMZ4S

[F-star, an invoX Company @Fstar_Inc]

Next week, our CEO @EliotForster will present at the @HCWCO 23rd annual Global #Investment Conference taking place virtually Sept 13-15. Details in our release with link to the video webcast.
https://t.co/GLYqkQ9UVf

[Jeremy Levin @jmaxlevin]

With rising out-of-pocket healthcare costs, the conversation around drug pricing is as important as ever; however, government dictation of pricing is not the answer. By disincentivizing investment in biotech, we stifle innovation. https://t.co/sEn4CrQ1zp

[F-star, an invoX Company @Fstar_Inc]

We announced today that we will host a full-year 2020 Investor call and webcast on March 29. CEO @EliotForster and CFO Darlene Deptula-Hicks will discuss financial results and provide a corporate update.
https://t.co/iG8ynJO6u9

[Nuno Prego Ramos @NunoPregoRamos]

https://t.co/4D86Hfiyop